Viridian Therapeutics, Inc.
22.37USD
-0.4500 (-1.97%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on VRDN.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$1.02▼ | -$0.93 | 1 | 0 |
| Next quarter | -$0.95▲ | -$0.96 | 1 | 0 |
| Current year | -$3.94▼ | -$3.8 | 1 | 0 |
| Next year | -$2.75▼ | -$2.63 | 1 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$1.03 | -$1.05 | -0.02 (-2.3%) |
| 2026-03-31 | -$1.08 | -$0.9 | +0.18 (+16.3%) |
| 2025-12-31 | -$1 | -$1.08 | -0.08 (-8.0%) |
| 2025-09-30 | -$0.94 | -$0.34 | +0.60 (+63.9%) |
131 ratings from 20 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $36 $38 | Sep 22, 2026 |
| RBC Capital | Maintained | Outperform | $35 $36 | Aug 7, 2026 |
| Truist Securities | Maintained | Buy | $38 $39 | Aug 7, 2026 |
| RBC Capital | Maintained | Outperform | $34 $35 | Jun 30, 2026 |
| Truist Securities | Maintained | Buy | $35 $38 | Jun 30, 2026 |
| Wedbush | Maintained | Outperform | $32 $43 | Jun 30, 2026 |
| Needham | Maintained | Buy | $32 $34 | Jun 30, 2026 |
| Wells Fargo | Upgraded from Equal-Weight | Overweight | $20 $31 | Jun 29, 2026 |
| Needham | Reiterated | Buy | $32 | Jun 29, 2026 |
| Evercore ISI Group | Maintained | Outperform | $27 $26 | May 15, 2026 |
| RBC Capital | Maintained | Outperform | $30 $34 | May 6, 2026 |
| Needham | Reiterated | Buy | $32 | May 5, 2026 |
| Truist Securities | Maintained | Buy | $36 $33 | Apr 21, 2026 |
| Wedbush | Maintained | Outperform | $37 $31 | Apr 8, 2026 |
| Goldman Sachs | Maintained | Buy | $36 $31 | Apr 7, 2026 |
| RBC Capital | Maintained | Outperform | $42 $30 | Apr 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $45 $32 | Apr 2, 2026 |
| Goldman Sachs | Maintained | Buy | $41 $36 | Mar 31, 2026 |
| Wedbush | Maintained | Outperform | $44 $37 | Mar 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $29 $20 | Mar 31, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $34 $22 | Mar 31, 2026 |
| Needham | Maintained | Buy | $42 $32 | Mar 30, 2026 |
| Wedbush | Reiterated | Outperform | $44 | Mar 11, 2026 |
| RBC Capital | Maintained | Outperform | $45 $42 | Feb 27, 2026 |
| Needham | Reiterated | Buy | $42 | Feb 4, 2026 |
11 filings from 6 insiders · 3 buy / 1 sell over 6m
Officers and directors of VRDN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| TOUSIGNANT JENNIFEROfficer | Exercise | 10.0k | $14.41 | $144k | Aug 19, 2026 |
| TOUSIGNANT JENNIFEROfficer | Sell | 14.2k | $24.50 | $348k | Aug 19, 2026 |
| TRIPURANENI RADHIKAOfficer | Exercise | 40.0k | $13.21 | $528k | Aug 14, 2026 |
| FAIRMOUNT FUNDS MANAGEMENT LLCBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 1.18M | $17.00 | $20.00M | May 11, 2026 |
| MAHONEY STEPHEN FChief Executive Officer | Other | 18.4k | — | — | Mar 3, 2026 |
| BEETHAM THOMAS WChief Operating Officer | Other | 9.4k | — | — | Mar 3, 2026 |
| TOUSIGNANT JENNIFEROfficer | Other | 5.2k | — | — | Mar 3, 2026 |
| HARMON SETHChief Financial Officer | Other | 6.3k | — | — | Mar 3, 2026 |
| TOUSIGNANT JENNIFEROfficer | Sell | 2.3k | $31.16 | $71k | Dec 31, 2025 |
| FAIRMOUNT FUNDS MANAGEMENT LLCDirector and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 454.5k | $22.00 | $10.00M | Oct 23, 2025 |
| FAIRMOUNT FUNDS MANAGEMENT LLCBeneficial Owner of more than 10% of a Class of Security | Exerciseindirect | 14.1k | $7.80 | $166k | Jun 10, 2025 |
No analyst notes on VRDN yet.
Members whose judged calls on VRDN have played out most reliably.
No settled calls on VRDN yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 14 | 0 | 0 | 0 | Buy1.82 |
| 1 mo ago | 3 | 14 | 0 | 0 | 0 | Buy1.82 |
| 2 mo ago | 3 | 14 | 0 | 0 | 0 | Buy1.82 |
| 3 mo ago | 3 | 14 | 0 | 0 | 0 | Buy1.82 |